IBDRespons: Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response
Trial Overview
| Acronym | IBDRespons |
|---|---|
| Number | NCT01974869 |
| Protocol Link | https://www.clinicaltrials.gov/ct2/show/record/NCT01974869?term=NCT01974869&rank=1 |
| Public Trial Registry Link | https://www.clinicaltrials.gov/ct2/show/record/NCT01974869?term=NCT01974869&rank=1 |
| Status | Closed |
| Category | IBD |
| Treatment Course | Surgery |
Trial Description
| Surgical stress response trigger a series of hormonal, haematological and immunological changes. TNF-alpha, produced as part of the surgical stress response, plays a key role in the initiation of collagen synthesis and angiogenesis. If anti-TNF α agents. |
Chief Investigator
|
Alaa El-Hussuna Consultant Surgeon |
| Profile Link |
Lead Centre
|
Slagelse Sygehus Ingemannsvej 18 Slagelse 4200 Denmark |
| Website |
Collaboration and Funding
Collaborative Sites
| 1. Køge Sygehus Lykkebækvej 1 Køge 4600 Denmark Website |
| 2. Odense University Hospital Søndre Blvd. 29 Odense C 5000 Denmark Website |
Additional Information
Full Research Summary| Objective: | . |
| Aim: | . |
| Methods: | . |
| Reason for International Trial: | . |